Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 18;21(2):1415-1426.
doi: 10.1007/s40200-022-01074-4. eCollection 2022 Dec.

Metformin inhibits cardiometabolic syndrome associated cognitive deficits in high fat diet rats

Affiliations

Metformin inhibits cardiometabolic syndrome associated cognitive deficits in high fat diet rats

Hanish Singh Jayasingh Chellammal et al. J Diabetes Metab Disord. .

Erratum in

Abstract

Objectives: Glucose intolerance and insulin resistance are hallmarks of metabolic syndrome and lead to Alzheimer's disease (AD). The purpose of this study is to elucidate the neuroprotective effect of metformin through insulin regulation with cardiometabolic and neurotransmitter metabolic enzyme regulation in high-fat, high-sucrose diet and streptozotocin (HFHS-STZ)-induced rats.

Methods: Male Wistar rats were treated with metformin (180 mg/kg and 360 mg/kg). STZ (35 mg/kg i.p.) injection was performed on the 14th day of 42 days of HFHS diet treatment. Brain neurotransmitter metabolic enzymes (acetylcholinesterase and monoamine oxidase) were determined along with sodium-potassium ATPase (Na+K+-ATPase). Plasma lipids and homeostasis model assessment of insulin resistance (HOMA-IR) was performed. Mean arterial blood pressure, heart rate and electrocardiogram (QT, QTc and RR intervals) were analysed with PowerLab.

Results: Metformin treatment significantly (p < 0.001) reduced the HOMA-IR index and decreased neurotransmitter metabolic enzymes such as AChE and MAO (p < 0.01 and p < 0.05). The lipid profile was significantly (p < 0.001) controlled with cardiometabolic functions.

Conclusions: Our investigation revealed that metformin has a remarkable role in regulating brain insulin, vascular system with monoaminergic metabolic enzymes and enhancing synaptic plasticity. Metformin may be a selective early therapeutic agent in metabolic syndrome associated with cognitive decline.

Keywords: Alzheimer’s disease; Cognitive dysfunction; Insulin resistance; Metabolic cardiovascular syndrome; Metformin; Neuroprotection.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflict of interestThe corresponding author states that there is no conflict of interest among all authors.

Figures

Fig. 1
Fig. 1
Body weight
Fig. 2
Fig. 2
Food intake
Fig. 3
Fig. 3
Oral glucose tolerance test

Similar articles

Cited by

References

    1. Wilson B, Geetha KM. Neurotherapeutic applications of nanomedicine for treating Alzheimer’s disease. J Control Release. 2020;325:25–37. doi: 10.1016/j.jconrel.2020.05.044. - DOI - PubMed
    1. Wahl D, Solon-Biet SM, Cogger VC, Fontana L, Simpson SJ, Le Couteur DG, Ribeiro RV. Aging, lifestyle and dementia. Neurobiol Dis. 2019;130:104481. doi: 10.1016/j.nbd.2019.104481. - DOI - PubMed
    1. Yeh SH-H, Shie F-S, Liu H-K, Yao H-H, Kao P-C, Lee Y-H, et al. A high-sucrose diet aggravates Alzheimer’s disease pathology, attenuates hypothalamic leptin signaling, and impairs food-anticipatory activity in APPswe/PS1dE9 mice. Neurobiol Aging. 2020;90:60–74. doi: 10.1016/j.neurobiolaging.2019.11.018. - DOI - PubMed
    1. Zhou C, Qin Y, Chen R, Gao F, Zhang J, Lu F. Fenugreek attenuates obesity-induced inflammation and improves insulin resistance through downregulation of iRhom2/TACE. Life Sci. 2020;258:118222. doi: 10.1016/j.lfs.2020.118222. - DOI - PubMed
    1. Woodie LN, Johnson RM, Ahmed B, Fowler S, Haynes W, Carmona B, et al. Western diet-induced obesity disrupts the diurnal rhythmicity of hippocampal core clock gene expression in a mouse model. Brain Behav Immun. 2020;88:815–25. doi: 10.1016/j.bbi.2020.05.053. - DOI - PubMed

LinkOut - more resources